<p>Survival analysis Kaplan–Meier curves according to <i>GSTO1</i> polymorphism for overall mortality (A), as well as mortality of TCC patients on chemotherapy (B).</p
(A) Survival curves for overall survival according to the median time from the start date of first-l...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>The solid curve represents cases with (CC) homozygous wild-type genotype as compared to the dashe...
<p>Survival analysis Kaplan–Meier curves according to <i>GSTO2</i> polymorphism for overall mortalit...
<p>A. Survival curves for patients in arm A, treated with CAPOX-B in first-line chemotherapy. B. Sur...
<p>(A) Survival curves for overall survival according to age. (B) Survival curves for overall surviv...
<p>(A) Survival curves for overall survival according to chemotherapy regimens in Group B (N = 114)....
<p>Kaplan-Meier curves showing the cumulative proportion of survival patients at 30 days and 6 month...
<p>Kaplan-Meier curves of overall survival of lung cancer patients with different genotypes at intro...
<p>(A), C1C2 or C2C2 genotype had a markedly poor overall survival, compared with C1C1 genotype (<i>...
<p>Kaplan–Meier curve of overall survival according to (A) <i>XPD Asp<sup>312</sup>Asn</i> polymorph...
<p>(A) Overall survival according to PIK3CA mutation status (P = 0.251). (B) Overall survival accord...
<p>(A) DFS curves of different PTS (pim-1 total score) in different groups of patients: 1, stage Ⅰ; ...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0071979#pone-0071979-g001" ...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) according to <...
(A) Survival curves for overall survival according to the median time from the start date of first-l...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>The solid curve represents cases with (CC) homozygous wild-type genotype as compared to the dashe...
<p>Survival analysis Kaplan–Meier curves according to <i>GSTO2</i> polymorphism for overall mortalit...
<p>A. Survival curves for patients in arm A, treated with CAPOX-B in first-line chemotherapy. B. Sur...
<p>(A) Survival curves for overall survival according to age. (B) Survival curves for overall surviv...
<p>(A) Survival curves for overall survival according to chemotherapy regimens in Group B (N = 114)....
<p>Kaplan-Meier curves showing the cumulative proportion of survival patients at 30 days and 6 month...
<p>Kaplan-Meier curves of overall survival of lung cancer patients with different genotypes at intro...
<p>(A), C1C2 or C2C2 genotype had a markedly poor overall survival, compared with C1C1 genotype (<i>...
<p>Kaplan–Meier curve of overall survival according to (A) <i>XPD Asp<sup>312</sup>Asn</i> polymorph...
<p>(A) Overall survival according to PIK3CA mutation status (P = 0.251). (B) Overall survival accord...
<p>(A) DFS curves of different PTS (pim-1 total score) in different groups of patients: 1, stage Ⅰ; ...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0071979#pone-0071979-g001" ...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) according to <...
(A) Survival curves for overall survival according to the median time from the start date of first-l...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>The solid curve represents cases with (CC) homozygous wild-type genotype as compared to the dashe...